Mild cognitive impairment in parkinson's disease: A review of current concepts

Neurology Research International

Volumn 2013, Issue , 2013, Pages

  Palavra, Natalie C ^a   Naismith, Sharon L ^a   Lewis, Simon J G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; RASAGILINE; RIVASTIGMINE;

ALZHEIMER DISEASE; ANTERIOR CINGULATE; BOLD SIGNAL; BRADYKINESIA; BRAIN METABOLISM; COGNITION; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DAYTIME SOMNOLENCE; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; EXECUTIVE FUNCTION; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GAIT DISORDER; GENOTYPE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MILD COGNITIVE IMPAIRMENT; MILD COGNITIVE IMPAIRMENT IN PARKINSON DISEASE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL LOBE; ONSET AGE; OXIDATIVE STRESS; PARKINSON DISEASE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN METABOLISM; REM SLEEP; REVIEW; SENSITIVITY AND SPECIFICITY; WHITE MATTER; WORKING MEMORY;

EID: 84880911560     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2013/576091     Document Type: Review

References (67)

1. Chaudhuri K. R., Healy D. G., Schapira A. H. V., Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurology 2006 5 3 235 245 2-s2.0-32544432029 10.1016/S1474-4422(06)70373-8 (Pubitemid 43238347)
2. Naismith S. L., Hickie I. B., Lewis S. J. G., The role of mild depression in sleep disturbance and quality of life in Parkinson's disease. Journal of Neuropsychiatry and Clinical Neurosciences 2010 22 4 384 389 2-s2.0-78149340435 10.1176/appi.neuropsych.22.4.384
3. Caviness J. N., Driver-Dunckley E., Connor D. J., Sabbagh M. N., Hentz J. G., Noble B., Evidente V. G. H., Shill H. A., Adler C. H., Defining mild cognitive impairment in Parkinson's disease. Movement Disorders 2007 22 9 1272 1277 2-s2.0-34548278878 10.1002/mds.21453 (Pubitemid 47325034)
4. Hely M. A., Reid W. G. J., Adena M. A., Halliday G. M., Morris J. G. L., The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Movement Disorders 2008 23 6 837 844 2-s2.0-41149173996 10.1002/mds.21956
5. Foltynie T., Brayne C. E. G., Robbins T. W., Barker R. A., The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004 127 3 550 560 2-s2.0-1542375990 10.1093/brain/awh067 (Pubitemid 38295472)
6. Schrag A., Jahanshahi M., Quinn N., What contributes to quality of life in patients with Parkinson's disease? Journal of Neurology Neurosurgery and Psychiatry 2000 69 3 308 312 2-s2.0-0033875826 10.1136/jnnp.69.3.308 (Pubitemid 30636233)
7. Aarsland D., Larsen J. P., Karlsen K., Lim N. G., Tandberg E., Mental symptoms in Parkinson's disease are important contributors to caregiver distress. International Journal of Geriatric Psychiatry 1999 14 866 874 (Pubitemid 29495548)
8. Aarsland D., Larsen J. P., Tandberg E., Laake K., Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. Journal of the American Geriatrics Society 2000 48 8 938 942 2-s2.0-0033895282 (Pubitemid 30637303)
9. Williams-Gray C. H., Foltynie T., Brayne C. E. G., Robbins T. W., Barker R. A., Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007 130 7 1787 1798 2-s2.0-34447633928 10.1093/brain/awm111 (Pubitemid 47343805)
10. Janvin C. C., Larsen J. P., Aarsland D., Hugdahl K., Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Movement Disorders 2006 21 9 1343 1349 2-s2.0-33750367778 10.1002/mds.20974 (Pubitemid 44613283)
11. Petersen R. C., Doody R., Kurz A., Mohs R. C., Morris J. C., Rabins P. V., Ritchie K., Rossor M., Thal L., Winblad B., Current concepts in mild cognitive impairment. Archives of Neurology 2001 58 12 1985 1992 2-s2.0-0035195760 (Pubitemid 33143977)
12. Knopman D. S., Boeve B. F., Petersen R. C., Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clinic Proceedings 2003 78 10 1290 1308 2-s2.0-0141705380 (Pubitemid 37193520)
13. Petersen R. C., Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004 256 3 183 194 2-s2.0-4544335597 10.1111/j.1365-2796. 2004.01388.x (Pubitemid 39222988)
14. Fernandez H. H., Crucian G. P., Okun M. S., Price C. C., Bowers D., Mild cognitive impairment in Parkinson's disease: the challenge and the promise. Neuropsychiatric Disease and Treatment 2005 1 1 37 50
15. Litvan I., Aarsland D., Adler C. H., Goldman J. G., Kulisevsky J., Mollenhauer B., Rodriguez-Oroz M. C., Tröster A. I., Weintraub D., MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Movement Disorders 2011 26 10 1814 1824 2-s2.0-80052267232 10.1002/mds.23823
16. Litvan I., Goldman J. G., Tröster A. I., Schmand B. A., Weintraub D., Petersen R. C., Mollenhauer B., Adler C. H., Marder K., Williams-Gray C. H., Aarsland D., Kulisevsky J., Rodriguez-Oroz M. C., Burn D. J., Barker R. A., Emre M., Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders 2012 27 3 349 356 2-s2.0-84858298114 10.1002/mds.24893
17. Naismith S. L., Lewis S. J. G., DASH symptoms in patients with Parkinson's disease: red flags for early cognitive decline. Journal of Clinical Neuroscience 2011 18 3 352 355 2-s2.0-79551531015 10.1016/j.jocn.2010.07.106
18. Naismith S. L., Pereira M., Shine J. M., Lewis S. J. G., How well do caregivers detect mild cognitive change in Parkinson's disease? Movement Disorders 2011 26 1 161 164 2-s2.0-79951484616 10.1002/mds.23331
19. Mamikonyan E., Moberg P. J., Siderowf A., Duda J. E., Have T. T., Hurtig H. I., Stern M. B., Weintraub D., Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism and Related Disorders 2009 15 3 226 231 2-s2.0-60649107807 10.1016/j.parkreldis.2008.05.006
20. Muslimović D., Post B., Speelman J. D., Schmand B., Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005 65 8 1239 1245 2-s2.0-27144549543 10.1212/01.wnl.0000180516.69442.95 (Pubitemid 41508217)
21. McKinlay A., Grace R. C., Dalrymple-Alford J. C., Roger D., Cognitive characteristics associated with mild cognitive impairment in parkinson's disease. Dementia and Geriatric Cognitive Disorders 2009 28 2 121 129 2-s2.0-68749111155 10.1159/000235247
22. Verbaan D., Marinus J., Visser M., Van Rooden S. M., Stiggelbout A. M., Middelkoop H. A. M., Van Hilten J. J., Cognitive impairment in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2007 78 11 1182 1187 2-s2.0-35748952827 10.1136/jnnp.2006.112367 (Pubitemid 350057278)
23. Tedrus G. M. A. S., Fonseca L. C., Letro G. H., Bossoni A. S., Samara A. B., Dementia and mild cognitive impairment in patients with Parkinson's disease. Arquivos de Neuro-Psiquiatria 2009 67 2B 423 427 2-s2.0-68049102213 10.1590/S0004-282X2009000300010
24. Lewis S. J. G., Foltynie T., Blackwell A. D., Bobbins T. W., Owen A. M., Barker R. A., Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. Journal of Neurology, Neurosurgery and Psychiatry 2005 76 3 343 348 2-s2.0-14544303625 10.1136/jnnp.2003.033530 (Pubitemid 40299121)
25. Reijnders J. S. A. M., Ehrt U., Lousberg R., Aarsland D., Leentjens A. F. G., The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism and Related Disorders 2009 15 5 379 382 2-s2.0-67349105922 10.1016/j.parkreldis.2008.09.003
26. Janvin C., Aarsland D., Larsen J. P., Hugdahl K., Neuropsychological profile of patients with Parkinson's disease without dementia. Dementia and Geriatric Cognitive Disorders 2003 15 3 126 131 2-s2.0-0037279168 10.1159/000068483 (Pubitemid 36206641)
27. Gagnon J.-F., Vendette M., Postuma R. B., Desjardins C., Massicotte-Marquez J., Panisset M., Montplaisir J., Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Annals of Neurology 2009 66 1 39 47 2-s2.0-69249126529 10.1002/ana.21680
28. Muslimović D., Schmand B., Speelman J. D., de Haan R. J., Course of cognitive decline in Parkinson's disease: a meta-analysis. Journal of the International Neuropsychological Society 2007 13 6 920 932 2-s2.0-35448996812 10.1017/S1355617707071160 (Pubitemid 47617543)
29. Janvin C. C., Aarsland D., Larsen J. P., Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study. Journal of Geriatric Psychiatry and Neurology 2005 18 3 149 154 2-s2.0-24644434376 10.1177/0891988705277540 (Pubitemid 41284965)
30. Aarsland D., Kvaløy J. T., Andersen K., Larsen J. P., Tang M. X., Lolk A., Kragh-Sørensen P., Marder K., The effect of age of onset of PD on risk of dementia. Journal of Neurology 2007 254 1 38 45 2-s2.0-33847151183 10.1007/s00415-006-0234-8 (Pubitemid 46295066)
31. Lachman H. M., Papolos D. F., Saito T., Yu Y.-M., Szumlanski C. L., Weinshilboum R. M., Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996 6 3 243 250 2-s2.0-0030004521 10.1097/00008571-199606000-00007 (Pubitemid 26226317)
32. 158met polymorphism. Movement Disorders 2004 19 8 885 891 2-s2.0-4444264056 10.1002/mds.20118 (Pubitemid 39199254)
33. 158met genotype influences frontoparietal activity during planning in patients with parkinson's disease. Journal of Neuroscience 2007 27 18 4832 4838 2-s2.0-34247897260 10.1523/JNEUROSCI.0774-07.2007 (Pubitemid 46699066)
34. 158met genotype. Brain 2008 131 2 397 408 2-s2.0-38849107545 10.1093/brain/awm313 (Pubitemid 351197617)
35. Williams-Gray C. H., Evans J. R., Goris A., Foltynie T., Ban M., Robbins T. W., Brayne C., Kolachana B. S., Weinberger D. R., Sawcer S. J., Barker R. A., The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009 132 11 2958 2969 2-s2.0-70350641659 10.1093/brain/awp245
36. Goris A., Williams-Gray C. H., Clark G. R., Foltynie T., Lewis S. J. G., Brown J., Ban M., Spillantini M. G., Compston A., Burn D. J., Chinnery P. F., Barker R. A., Sawcer S. J., Tau and -synuclein in susceptibility to, and dementia in, Parkinson's disease. Annals of Neurology 2007 62 2 145 153 2-s2.0-35148866228 10.1002/ana.21192 (Pubitemid 47546500)
37. Setó-Salvia N., Clarimón J., Pagonabarraga J., Pascual-Sedano B., Campolongo A., Combarros O., Mateo J. I., Regaña D., Martínez-Corral M., Marquié M., Alcolea D., Suárez-Calvet M., Molina-Porcel L., Dols O., Gómez-Isla T., Blesa R., Lleó A., Kulisevsky J., Dementia risk in parkinson disease: disentangling the role of MAPT Haplotypes. Archives of Neurology 2011 68 3 359 364 2-s2.0-79952602802 10.1001/archneurol.2011.17
38. Beyer M. K., Janvin C. C., Larsen J. P., Aarsland D., A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. Journal of Neurology, Neurosurgery and Psychiatry 2007 78 3 254 259 2-s2.0-33847714701 10.1136/jnnp.2006.093849 (Pubitemid 46579662)
39. Camicioli R., Moore M. M., Kinney A., Corbridge E., Glassberg K., Kaye J. A., Parkinson's disease is associated with hippocampal atrophy. Movement Disorders 2003 18 7 784 790 2-s2.0-0041589706 10.1002/mds.10444 (Pubitemid 36939973)
40. Ramírez-Ruiz B., Martí M. J., Tolosa E., Bartrés-Faz D., Summerfield C., Salgado-Pineda P., Gómez-Ansón B., Junqué C., Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. Journal of Neurology 2005 252 11 1345 1352 2-s2.0-25144513700 10.1007/s00415-005-0864-2 (Pubitemid 41699025)
41. Weintraub D., Doshi J., Koka D., Davatzikos C., Siderowf A. D., Duda J. E., Wolk D. A., Moberg P. J., Xie S. X., Clark C. M., Neurodegeneration across stages of cognitive decline in Parkinson disease. Archives of Neurology 2011 68 12 1562 1568 2-s2.0-83455225206
42. Brück A., Kurki T., Kaasinen V., Vahlberg T., Rinne J. O., Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. Journal of Neurology, Neurosurgery and Psychiatry 2004 75 10 1467 1469 2-s2.0-4644277646 10.1136/jnnp.2003.031237 (Pubitemid 39279819)
43. Dalaker T. O., Zivadinov R., Larsen J. P., Beyer M. K., Cox J. L., Alves G., Bronnick K., Tysnes O.-B., Antulov R., Dwyer M. G., Aarsland D., Gray matter correlations of cognition in incident Parkinson's disease. Movement Disorders 2010 25 5 629 633 2-s2.0-77951247114 10.1002/mds.22867
44. Huang C., Mattis P., Perrine K., Brown N., Dhawan V., Eidelberg D., Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 2008 70 16, part 2 1470 1477 2-s2.0-42049122792 10.1212/01.wnl.0000304050.05332.9c (Pubitemid 351521942)
45. Lewis S. J. G., Shine J. M., Duffy S., Halliday G., Naismith S. L., Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease. Movement Disorders 2012 27 10 1262 1267
46. 18FDG-PET study. Brain 2000 123 2 340 352 2-s2.0-0033967662 (Pubitemid 30055157)
47. Camicioli R. M., Korzan J. R., Foster S. L., Fisher N. J., Emery D. J., Bastos A. C., Hanstock C. C., Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neuroscience Letters 2004 354 3 177 180 2-s2.0-0345791457 10.1016/j.neulet.2003.09.076 (Pubitemid 38045338)
48. Rinne J. O., Portin R., Ruottinen H., Nurmi E., Bergman J., Haaparanta M., Solin O., Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Archives of Neurology 2000 57 4 470 475 2-s2.0-0034037276 (Pubitemid 30212118)
49. Lewis S. J. G., Dove A., Robbins T. W., Barker R. A., Owen A. M., Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. Journal of Neuroscience 2003 23 15 6351 6356 2-s2.0-0037705985 (Pubitemid 36875637)
50. Fonseca L. C., Tedrus G. M. A. S., Letro G. H., Bossoni A. S., Dementia, mild cognitive impairment and quantitative EEG in patients with Parkinson's disease. Clinical EEG and Neuroscience 2009 40 3 168 172 2-s2.0-68549140042
51. Kamei S., Morita A., Serizawa K., Mizutani T., Hirayanagi K., Quantitative EEG analysis of executive dysfunction in Parkinson disease. Journal of Clinical Neurophysiology 2010 27 3 193 197 2-s2.0-77953361631 10.1097/WNP.0b013e3181dd4fdb
52. Siderowf A., Xie S. X., Hurtig H., Weintraub D., Duda J., Chen-Plotkin A., Shaw L. M., Van Deerlin V., Trojanowski J. Q., Clark C., CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease. Neurology 2010 75 12 1055 1061 2-s2.0-77957220702 10.1212/WNL.0b013e3181f39a78
53. Alves G., Brønnick K., Aarsland D., Blennow K., Zetterberg H., Ballard C., Kurz M. W., Andreasson U., Tysnes O.-B., Larsen J. P., Mulugeta E., CSF amyloid- β and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. Journal of Neurology, Neurosurgery and Psychiatry 2010 81 10 1080 1086 2-s2.0-77958071837 10.1136/jnnp.2009.199950
54. Noguchi M., Yoshita M., Matsumoto Y., Ono K., Iwasa K., Yamada M., Decreased β -amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. Journal of the Neurological Sciences 2005 237 1-2 61 65 2-s2.0-25644432885 10.1016/j.jns.2005. 05.015 (Pubitemid 41384015)
55. Gomperts S. N., Rentz D. M., Moran E., Becker J. A., Locascio J. J., Klunk W. E., Mathis C. A., Elmaleh D. R., Shoup T., Fischman A. J., Hyman B. T., Growdon J. H., Johnson K. A., Imaging amyloid deposition in lewy body diseases. Neurology 2008 71 12 903 910 2-s2.0-54049100454 10.1212/01.wnl.0000326146. 60732.d6
56. Schulz-Schaeffer W. J., The synaptic pathology of -synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathologica 2010 120 2 131 143 2-s2.0-77957264418 10.1007/s00401-010-0711-0
57. Zhang J., Proteomics of human cerebrospinal fluid-the good, the bad, and the ugly. Proteomics-Clinical Applications 2007 1 8 805 819 2-s2.0-38049062265 10.1002/prca.200700081
58. Leroi I., Brandt J., Reich S. G., Lyketsos C. G., Grill S., Thompson R., Marsh L., Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. International Journal of Geriatric Psychiatry 2004 19 1 1 8 2-s2.0-0842325101 10.1002/gps.993 (Pubitemid 38180686)
59. Emre M., Aarsland D., Albanese A., Byrne E. J., Deuschl G., De Deyn P. P., Durif F., Kulisevsky J., Van Laar T., Lees A., Poewe W., Robillard A., Rosa M. M., Wolters E., Quarg P., Tekin S., Lane R., Rivastigmine for dementia associated with Parkinson's disease. The New England Journal of Medicine 2004 351 24 2509 2518 2-s2.0-10044283107 10.1056/NEJMoa041470 (Pubitemid 39603164)
60. Maidment I., Fox C., Boustani M., Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database of Systematic Reviews 2006 1 CD004747 2-s2.0-33645520639
61. Almaraz A. C., Driver-Dunckley E. D., Woodruff B. K., Wellik K. E., Caselli R. J., Demaerschalk B. M., Adler C. H., Caviness J. N., Wingerchuk D. M., Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. The Neurologist 2009 15 4 234 237 2-s2.0-70349763571 10.1097/NRL.0b013e3181a968df
62. Rolinski M., Fox C., Maidment I., McShane R., Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database of Systematic Reviews 2012 3 2-s2.0-44949228366 10.1002/14651858.CD006504.pub2 CD006504
63. Hanagasi H. A., Gurvit H., Unsalan P., Horozoglu H., Tuncer N., Feyzioglu A., Gunal D. I., Yener G. G., Cakmur R., Sahin H. A., Emre M., The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study. Movement Disorders 2011 26 10 1851 1858 2-s2.0-80052284729 10.1002/mds.23738
64. Mowszowski L., Batchelor J., Naismith S. L., Early intervention for cognitive decline: can cognitive training be used as a selective prevention technique? International Psychogeriatrics 2010 22 4 537 548 2-s2.0-77952430629 10.1017/S1041610209991748
65. París A. P., Saleta H. G., de la Cruz Crespo Maraver M., Silvestre E., Freixa M. G., Torrellas C. P., Pont S. A., Nadal M. F., Garcia S. A., Bartolomé M. V. P., Fernández V. L., Bayés À. R., Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease. Movement Disorders 2011 26 7 1251 1258 2-s2.0-79959350034 10.1002/mds.23688
66. Nombela C., Bustillo P. J., Castel P. F., Sanchez L., Medina V., Herrero M. T., Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Frontiers in Neurology 2011 2 82
67. Aarsland D., Bronnick K., Larsen J. P., Tysnes O. B., Alves G., Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009 72 1121 1126